XAIR Stock Analysis: Buy, Sell, or Hold?
XAIR - Beyond Air, Inc. Common Stock
$1.19
-0.04 (-3.25%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 09, 2026
9d
Get Alerted When XAIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: XAIR is down 26.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: XAIR is down 26.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: XAIR is currently trading at $1.19, which is considered fair relative to its 30-day fair value range of $0.75 to $1.66.
Technical Outlook: Technically, XAIR is in a strong downtrend. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.33 (+740.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XAIR is in a strong downtrend. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.33 (+740.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.75 -
$1.66
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
64.2%
Protect Your Profits
Holding XAIR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 740.1% below Wall St target ($10.33)
- WARNING: Recommendation downgraded due to -26.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.75 -
$1.66
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$2.26
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.93
Wall Street Target
$10.33
(+740.1%)
Revenue Growth (YoY)
127.8%
Last updated: January 30, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
Data refreshes hourly during market hours. Next update: 6:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XAIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced XAIR Option Strategies
Professional options setups generated by AI based on today's XAIR price and gamma walls.
